Sodium intake and multiple sclerosis activity and progression in BENEFIT

Annals of Neurology

Volumn 82, Issue 1, 2017, Pages 20-29

  Fitzgerald, Kathryn C ^a   Munger, Kassandra L ^b   Hartung, H P ⁱ   Freedman, M ⁱ   Montalbán, Xavier ^e   Edan, G ⁱ   Wicklein, Eva Maria ^g   Radue, Ernst Wilhelm ^h   Kappos, L ⁱ   Pohl, Christoph ^g   Ascherio, Alberto ^b   Strasser Fuchs, S ⁱ   Berger, T ⁱ   Vass, K ⁱ   Sindic, C ⁱ   Dubois, B ⁱ   Dive, D ⁱ   Debruyne, J ⁱ   Metz, L ⁱ   Rice, G ⁱ   Duquette, P ⁱ   Lapierre, Y ⁱ   Traboulsee, A ⁱ   O'Connor, P ⁱ   Stourac P ⁱ   Talab, R ⁱ   Zapletalova, O ⁱ   Kovarova I ⁱ   Medova, E ⁱ   Fiedler, J ⁱ   Frederiksen, J ⁱ   Brochet, B ⁱ   Moreau, T ⁱ   Vermersch, P ⁱ   Pelletier, J ⁱ   Clanet, M ⁱ   Clavelou, P ⁱ   Lebrun Frenay, C ⁱ   Gout, O ⁱ   Kallela, M ⁱ   Pirttila, T ⁱ   Ruutiainen, J ⁱ   Koivisto, K ⁱ   Reunanen, M ⁱ   Elovaara, I ⁱ   Villringer, A ⁱ   Altenkirch, H ⁱ   Wessel, K ⁱ   Steinke, W ⁱ   Kolmel H ⁱ   Oschmann, P ⁱ   Diem, R ⁱ   Dressel, A ⁱ   Hoffmann, F ⁱ   Baum, K ⁱ   Jung, S ⁱ   Petereit, H ⁱ   Reske, D ⁱ   Sailer, M ⁱ   Kohler, J ⁱ   Sommer, N ⁱ   Hohlfeld, R ⁱ   Henn, K H ⁱ   Tumani, H ⁱ   Gold, R ⁱ   Rieckmann, P ⁱ   Komoly, R ⁱ   Gacs, G ⁱ   Jakab, G ⁱ   Csiba, L ⁱ   Vecsei, L ⁱ   Miller, A ⁱ   Karussis, D ⁱ   Chapman, J ⁱ   Ghezzi, A ⁱ   Comi, G ⁱ   Gallo, P ⁱ   Cosi, V ⁱ   Durelli, L ⁱ   Anten, B ⁱ   Visser, L ⁱ   Myhr, K M ⁱ   Szczudlik, A ⁱ   Selmaj, K ⁱ   Stelmasiak, Z ⁱ   Podemski, R ⁱ   Maciejek, Z ⁱ   Cunha, L ⁱ   Sega Jazbec, S ⁱ   Saiz, A ⁱ   Barcena, J ⁱ   Arroyo, R ⁱ   Fernandez, O ⁱ   Izquierdo, G ⁱ   Casanova, B ⁱ   Lycke, J ⁱ   Mattle, H ⁱ   Beer, K ⁱ   Coleman, R ⁱ   Chataway, J ⁱ   Riordan, J O ⁱ   Howell, S ⁱ   more..

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c Department of Orthopedic Surgery   (Germany)

^d OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^e HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^f PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^g BAYER AG   (Germany)

^h UNIVERSITY HOSPITAL BASEL   (Switzerland)

ⁱ NONE

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; CREATININE; INTERFERON BETA SERINE; SODIUM; SODIUM INTAKE;

ADULT; ARTICLE; BODY MASS; BRAIN SIZE; CONTROLLED STUDY; CREATININE URINE LEVEL; DEMYELINATING DISEASE; DISEASE ACTIVITY; DISEASE COURSE; DOSE RESPONSE; EXPANDED DISABILITY STATUS SCALE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENCE RISK; RELAPSE; SALT INTAKE; SODIUM BALANCE; SODIUM EXCRETION; SODIUM INTAKE; SODIUM URINE LEVEL; URINE SAMPLING; ADVERSE EFFECTS; BRAIN; DEMYELINATING DISEASES; DISABILITY; NEUROIMAGING; PATHOLOGY; URINE; YOUNG ADULT;

ADULT; BRAIN; DEMYELINATING DISEASES; DISABILITY EVALUATION; DISEASE PROGRESSION; FEMALE; HUMANS; INTERFERON BETA-1B; MAGNETIC RESONANCE IMAGING; MALE; MULTIPLE SCLEROSIS; NEUROIMAGING; SODIUM, DIETARY; YOUNG ADULT;

EID: 85025639140     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.24965     Document Type: Article

References (27)

1. Ascherio A, Munger KL, Lünemann JD. The initiation and prevention of multiple sclerosis. Nat Rev Neurol 2012;8:602–612.
2. International Multiple Sclerosis Genetics Consortium et al. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 2011;476:214–219.
3. Ascherio A. Environmental factors in multiple sclerosis. Expert Rev Neurother 2013;13:3–9.
4. Wu C, Yosef N, Thalhamer T, et al. Induction of pathogenic TH17 cells by inducible salt-sensing kinase SGK1. Nature 2013;496:513–517.
5. Kleinewietfeld M, Manzel A, Titze J, et al. Sodium chloride drives autoimmune disease by the induction of pathogenic TH17 cells. Nature 2013;496:518–522.
6. McDonald J, Graves J, Waldman A, et al. A case-control study of dietary salt intake in pediatric-onset multiple sclerosis. Mult Scler Relat Disord 2016;6:87–92.
7. Nourbakhsh B, Graves J, Casper TC, et al. Dietary salt intake and time to relapse in paediatric multiple sclerosis. J Neurol Neurosurg Psychiatry 2016;87:1350–1353.
8. Farez MF, Fiol MP, Gaitán MI, et al. Sodium intake is associated with increased disease activity in multiple sclerosis. J Neurol Neurosurg Psychiatry 2015;86:26–31.
9. Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983;13:227–231.
10. McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the Diagnosis of Multiple Sclerosis. Ann Neurol 2001;50:121–127.
11. Kappos L, Polman CH, Freedman MS, et al. Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes. Neurology 2006;67:1242–1249.
12. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33:1444–1452.
13. Moraal B, Pohl C, Uitdehaag BM, et al. Magnetic resonance imaging predictors of conversion to multiple sclerosis in the BENEFIT study. Arch Neurol 2009;66:1345–1352.
14. Smith SM, Zhang Y, Jenkinson M, et al. Accurate, robust, and automated longitudinal and cross-sectional brain change analysis. Neuroimage 2002;17:479–489.
15. Tanaka T, Okamura T, Miura K, et al. A simple method to estimate populational 24-h urinary sodium and potassium excretion using a casual urine specimen. J Hum Hypertens 2002;16:97–103.
16. Dyer AR, Shipley M, Elliott P. Urinary electrolyte excretion in 24 hours and blood pressure in the INTERSALT Study. I. Estimates of reliability. The INTERSALT Cooperative Research Group. Am J Epidemiol 1994;139:927–939.
17. Beaton GH, Milner J, Corey P, et al. Sources of variance in 24-hour dietary recall data: implications for nutrition study design and interpretation. Am J Clin Nutr 1979;32:2546–2559.
18. Liu K, Cooper R, McKeever J, et al. Assessment of the association between habitual salt intake and high blood pressure: methodological problems. Am J Epidemiol 1979;110:219–226.
19. Maronde RF, Milgrom M, Vlachakis ND, Chan L. Response of thiazide-induced hypokalemia to amiloride. JAMA 1983;249:237–241.
20. Bock HA, Stein JH. Diuretics and the control of extracellular fluid volume: role of counterregulation. Semin Nephrol 1988;8:264–272.
21. Mann SJ, Gerber LM. Estimation of 24-hour sodium excretion from spot urine samples. J Clin Hypertens (Greenwich) 2010;12:174–180.
22. Kawasaki T, Itoh K, Uezono K, Sasaki H. A simple method for estimating 24 h urinary sodium and potassium excretion from second morning voiding urine specimen in adults. Clin Exp Pharmacol Physiol 1993;20:7–14.
23. O'Donnell MJ, Yusuf S, Mente A, et al. Urinary sodium and potassium excretion and risk of cardiovascular events. JAMA 2011;306:2229–2238.
24. Cogswell ME, Wang CY, Chen TC, et al. Validity of predictive equations for 24-h urinary sodium excretion in adults aged 18-39 y. Am J Clin Nutr 2013;98:1502–1513.
25. Rimm EB, Giovannucci EL, Stampfer MJ, et al. Reproducibility and validity of an expanded self-administered semiquantitative food frequency questionnaire among male health professionals. Am J Epidemiol 1992;135:1114–1126; discussion 1127–1136.
26. Day N, McKeown N, Wong M, et al. Epidemiological assessment of diet: a comparison of a 7-day diary with a food frequency questionnaire using urinary markers of nitrogen, potassium and sodium. Int J Epidemiol 2001;30:309–317.
27. Hernandez AL, Kitz A, Wu C, et al. Sodium chloride inhibits the suppressive function of FOXP3+ regulatory T cells. J Clin Invest 2015;125:4212–4222.